🇺🇸 FDA
Pipeline program

Regimen:BIC+FTC+TAF

CO-US-380-7381

Approved small_molecule active

Quick answer

Regimen:BIC+FTC+TAF for HIV Infection is a Approved program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
HIV Infection
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials